Valuation: Attana AB

Market Cap 7.74M 817K 707K 660K 605K 1.14M 77.74M 1.16M 3.04M 38.97M 3.07M 3M 129M P/E 2024
-0.31x
P/E 2025 -1.11x
Enterprise Value 7.6M 802K 693K 647K 594K 1.12M 76.28M 1.13M 2.98M 38.24M 3.01M 2.94M 126M EV / Sales 2024
0.57x
EV / Sales 2025 5x
Free-Float
1.63%
Yield 2024 *
-
Yield 2025 -
3 months-57.14%
6 months-62.50%
Current year-66.67%
1 week 0
Extreme 0.003
0
1 month 0
Extreme 0.002
0
Current year 0
Extreme 0.002
0.01
1 year 0
Extreme 0.002
0.02
3 years 0
Extreme 0.002
0.29
5 years 0
Extreme 0.002
1.55
10 years 0
Extreme 0.002
2.4
Manager TitleAgeSince
Chief Executive Officer - 31/03/2025
Chief Executive Officer 56 31/08/2002
Director of Finance/CFO - -
Director TitleAgeSince
Director/Board Member 56 05/08/2012
Chairman 63 30/09/2015
Director/Board Member 62 31/12/2017
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%-86.36%-99.01% 817K
+3.83%+5.08%-38.18%-41.67% 633M
-12.64%-3.27%+101.69% - 349M
-1.34%+12.76%-35.31%-15.24% 125M
-5.51%-7.69%-0.41%+51.90% 98.97M
Average -3.13%+0.52%-11.72%-26.00% 241.27M
Weighted average by Cap. -2.24%+0.89%+5.68%-27.07%

Financials

2024 2025
Net sales 6.61M 698K 604K 564K 517K 973K 66.41M 988K 2.6M 33.29M 2.62M 2.56M 110M 4.01M 423K 366K 342K 313K 589K 40.25M 599K 1.57M 20.17M 1.59M 1.55M 66.69M
Net income -12.78M -1.35M -1.17M -1.09M -999K -1.88M -128M -1.91M -5.01M -64.31M -5.06M -4.95M -213M -10.5M -1.11M -959K -895K -821K -1.54M -105M -1.57M -4.12M -52.86M -4.16M -4.07M -175M
Net Debt 1.17M 124K 107K 99.81K 91.56K 172K 11.76M 175K 460K 5.89M 464K 454K 19.48M -145K -15.35K -13.27K -12.4K -11.37K -21.39K -1.46M -21.73K -57.08K -732K -57.63K -56.37K -2.42M
Logo Attana AB
Attana AB is a Sweden-based biotechnology company specializing in in vitro characterization of molecular interactions mimicking in vivo conditions. The Company develops proprietary label-free biosensors, based on the Quartz Crystal Microbalance (QCM) technology, for biochemical, crude, sera and cell-based assays. Its products and research services are used by pharmaceutical and biotechnology companies to quality control the production line of a biological pharmaceutical or gain insight into advanced dynamic features of target molecules, as well as by academic institutions within the life sciences. Attana’s biosensors are used to determine specificity, kinetics and affinity, among other binding characteristics of biomolecules and macrostructures of varying species such as cells, antibodies, proteins, viruses and bacteria.
Employees
6
Date Price Change Volume
07/08/26 SEK 0.003000 0.00% 5,816,367
06/08/26 SEK 0.003000 0.00% 1,879,102
05/08/26 SEK 0.003000 0.00% 81,048,841
04/08/26 SEK 0.003000 0.00% 1,681,566
03/08/26 SEK 0.003000 0.00% 9,884,660
  1. Stock Market
  2. Stocks
  3. ATANA Stock